Published in Exp Dermatol on January 01, 2004
Targeting the dynamic HSP90 complex in cancer. Nat Rev Cancer (2010) 6.81
Role of acetylation and extracellular location of heat shock protein 90alpha in tumor cell invasion. Cancer Res (2008) 1.88
Secretion of extracellular hsp90alpha via exosomes increases cancer cell motility: a role for plasminogen activation. BMC Cancer (2010) 1.51
The regulatory mechanism of Hsp90alpha secretion and its function in tumor malignancy. Proc Natl Acad Sci U S A (2009) 1.48
A small molecule cell-impermeant Hsp90 antagonist inhibits tumor cell motility and invasion. Oncogene (2007) 1.48
Hsp90, an unlikely ally in the war on cancer. FEBS J (2013) 1.33
Extracellular heat shock protein (Hsp)70 and Hsp90α assist in matrix metalloproteinase-2 activation and breast cancer cell migration and invasion. PLoS One (2011) 1.25
Secreted heat shock protein 90alpha induces colorectal cancer cell invasion through CD91/LRP-1 and NF-kappaB-mediated integrin alphaV expression. J Biol Chem (2010) 1.23
Targeting Hsp90 with small molecule inhibitors induces the over-expression of the anti-apoptotic molecule, survivin, in human A549, HONE-1 and HT-29 cancer cells. Mol Cancer (2010) 1.17
A novel extracellular Hsp90 mediated co-receptor function for LRP1 regulates EphA2 dependent glioblastoma cell invasion. PLoS One (2011) 1.17
Identification and analysis of tumour-associated antigens in hepatocellular carcinoma. Br J Cancer (2005) 1.16
Hsp90 inhibitors and drug resistance in cancer: the potential benefits of combination therapies of Hsp90 inhibitors and other anti-cancer drugs. Biochem Pharmacol (2011) 1.10
Heat shock protein 90α (HSP90α), a substrate and chaperone of DNA-PK necessary for the apoptotic response. Proc Natl Acad Sci U S A (2012) 1.01
Impact of heat-shock protein 90 on cancer metastasis. Future Oncol (2009) 1.00
Secreted Hsp90 is a novel regulator of the epithelial to mesenchymal transition (EMT) in prostate cancer. J Biol Chem (2012) 0.99
Extracellular Hsp90 serves as a co-factor for NF-κB activation and cellular pathogenesis induced by an oncogenic herpesvirus. Am J Cancer Res (2011) 0.98
Transactivation of the epidermal growth factor receptor by heat shock protein 90 via Toll-like receptor 4 contributes to the migration of glioblastoma cells. J Biol Chem (2010) 0.97
Chaperone proteins and brain tumors: potential targets and possible therapeutics. Neuro Oncol (2005) 0.97
Proteomic analyses reveal high expression of decorin and endoplasmin (HSP90B1) are associated with breast cancer metastasis and decreased survival. PLoS One (2012) 0.96
Biomarkers: the useful and the not so useful--an assessment of molecular prognostic markers for cutaneous melanoma. J Invest Dermatol (2010) 0.95
Secreted heat shock protein 90α (HSP90α) induces nuclear factor-κB-mediated TCF12 protein expression to down-regulate E-cadherin and to enhance colorectal cancer cell migration and invasion. J Biol Chem (2013) 0.95
HSP90 manages the ends. Trends Biochem Sci (2010) 0.93
Extracellular heat shock protein HSP90beta secreted by MG63 osteosarcoma cells inhibits activation of latent TGF-beta1. Biochem Biophys Res Commun (2010) 0.92
Impact of butyrate on PKM2 and HSP90β expression in human colon tissues of different transformation stages: a comparison of gene and protein data. Genes Nutr (2011) 0.87
The complex function of hsp70 in metastatic cancer. Cancers (Basel) (2013) 0.87
Extracellular molecules involved in cancer cell invasion. Cancers (Basel) (2015) 0.85
Extracellular heat shock proteins: a new location, a new function. Shock (2013) 0.85
Differential heat shock protein localization in chronic lymphocytic leukemia. J Leukoc Biol (2009) 0.84
Functions of heat shock proteins in pathways of the innate and adaptive immune system. J Immunol (2014) 0.82
The double-edged sword: conserved functions of extracellular hsp90 in wound healing and cancer. Cancers (Basel) (2014) 0.82
Effect of culture at low oxygen tension on the expression of heat shock proteins in a panel of melanoma cell lines. PLoS One (2012) 0.81
Hsp90 binds directly to fibronectin (FN) and inhibition reduces the extracellular fibronectin matrix in breast cancer cells. PLoS One (2014) 0.81
Hsps are up-regulated in melanoma tissue and correlate with patient clinical parameters. Cell Stress Chaperones (2012) 0.79
Identification of heat shock protein 90α as an IMH-2 epitope-associated protein and correlation of its mRNA overexpression with colorectal cancer metastasis and poor prognosis. Int J Colorectal Dis (2011) 0.78
Cancer associated missense mutations in BAP1 catalytic domain induce amyloidogenic aggregation: A new insight in enzymatic inactivation. Sci Rep (2015) 0.77
Interactions between Hsp90 and oncogenic viruses: implications for viral cancer therapeutics. Am J Cancer Res (2011) 0.76
Selection and Characterization of Single Chain Antibody Fragments Specific for Hsp90 as a Potential Cancer Targeting Molecule. Int J Mol Sci (2015) 0.75
Adapt, Recycle, and Move on: Proteostasis and Trafficking Mechanisms in Melanoma. Front Oncol (2016) 0.75
Cell surface heparan sulfate proteoglycans are involved in the binding of Hsp90α and Hsp90β to the cell plasma membrane. Cell Adh Migr (2015) 0.75
HSP90 Inhibitor Geldanamycin as a Radiation Response Modificator in Human Blood Cells. Dose Response (2015) 0.75
Knock-down of Hdj2/DNAJA1 co-chaperone results in an unexpected burst of tumorigenicity of C6 glioblastoma cells. Oncotarget (2016) 0.75
Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA (1999) 11.23
Optical response of high-dielectric-constant perovskite-related oxide. Science (2001) 6.70
An Arabidopsis mutant defective in the general phenylpropanoid pathway. Plant Cell (1992) 6.39
Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy. J Leukoc Biol (2006) 2.79
[Skin cancer screening in Germany : The situation in 2014 with suggestions for the future]. Hautarzt (2015) 2.29
Differences in efficacy between intention-to-treat and per-protocol analyses for patients with psoriasis vulgaris and atopic dermatitis: clinical and pharmacoeconomic implications. Br J Dermatol (2001) 2.05
The ABCD rule of dermatoscopy. High prospective value in the diagnosis of doubtful melanocytic skin lesions. J Am Acad Dermatol (1994) 1.94
DNA rehybridization during PCR: the 'Cot effect' and its consequences. Nucleic Acids Res (1996) 1.93
Successful and safe use of 2 min cold atmospheric argon plasma in chronic wounds: results of a randomized controlled trial. Br J Dermatol (2012) 1.78
Lipopolysaccharide and ceramide docking to CD14 provokes ligand-specific receptor clustering in rafts. Eur J Immunol (2001) 1.68
Oxygen in acute and chronic wound healing. Br J Dermatol (2010) 1.56
[Psoriatic onycho-pachydermo- periostitis]. Z Rheumatol (2002) 1.56
[Postoperative adjuvant therapy with interferon alfa-2B following laser surgery of condylomata acuminata]. Hautarzt (1990) 1.54
Glycosyltransferases in secondary plant metabolism: tranquilizers and stimulant controllers. Planta (2001) 1.54
[Diagnosis and therapy of carpal tunnel syndrome--guideline of the German Societies of Handsurgery, Neurosurgery, Neurology, Orthopaedics, Clinical Neurophysiology and Functional Imaging, Plastic, Reconstructive and Aesthetic Surgery, and Surgery for Traumatology]. Handchir Mikrochir Plast Chir (2007) 1.51
Bimoclomol: a nontoxic, hydroxylamine derivative with stress protein-inducing activity and cytoprotective effects. Nat Med (1997) 1.50
A first prospective randomized controlled trial to decrease bacterial load using cold atmospheric argon plasma on chronic wounds in patients. Br J Dermatol (2010) 1.45
Mycophenolate mofetil and cyclosporin treatment for recalcitrant pyoderma gangrenosum. Lancet (1997) 1.43
Metastatic signet-ring cell melanoma in a patient with an unknown primary tumor. Histologic, immunohistochemical, and ultrastructural findings. J Am Acad Dermatol (1992) 1.43
Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma. Cancer Res (1997) 1.42
Cutaneous pseudolymphoma induced by Cimicifuga racemosa. Dermatology (2007) 1.42
Ataxia-telangiectasia (Louis-Bar syndrome) associated with ulcerating necrobiosis lipoidica. J Am Acad Dermatol (1994) 1.40
Unilateral localized basaliomatosis: treatment with topical photodynamic therapy after application of 5-aminolevulinic acid. Dermatology (1995) 1.40
In situ localization of IgG in epidermolysis bullosa acquisita by immunogold technique. J Am Acad Dermatol (1992) 1.40
[Encephalopathy following poisoning with an anticholinergic agent]. Dtsch Med Wochenschr (1994) 1.39
Granuloma pyogenicum as a complication of flashlamp-pumped pulsed dye laser. Dermatology (1994) 1.39
[CO(2) laser vaporisation of actinic cheilitis]. Hautarzt (1999) 1.38
Management of nevus spilus. Pediatr Dermatol (1999) 1.38
Definition of extracellular localized epitopes of Hsp70 involved in an NK immune response. Cell Stress Chaperones (1998) 1.36
Photo-oxidative killing of human colonic cancer cells using indocyanine green and infrared light. Br J Cancer (1999) 1.33
Dual function of membrane-bound heat shock protein 70 (Hsp70), Bag-4, and Hsp40: protection against radiation-induced effects and target structure for natural killer cells. Cell Death Differ (2005) 1.28
Critical involvement of transmembrane tumor necrosis factor-alpha in endothelial programmed cell death mediated by ionizing radiation and bacterial endotoxin. Blood (1995) 1.28
Hsp70 plasma membrane expression on primary tumor biopsy material and bone marrow of leukemic patients. Cell Stress Chaperones (2000) 1.28
Mass mailing and staff experience in a total recruitment program for a clinical trial: the SHEP experience. Systolic Hypertension in the Elderly Program. Cooperative Research Group. Control Clin Trials (1999) 1.26
Regulated expression of cytokines in human endometrium throughout the menstrual cycle: dysregulation in habitual abortion. Mol Hum Reprod (2000) 1.23
Indocyanine green: intracellular uptake and phototherapeutic effects in vitro. J Photochem Photobiol B (1997) 1.22
Improvement of early recognition of lentigo maligna using dermatoscopy. J Am Acad Dermatol (2000) 1.22
Inhibitory effects of 13-cis-retinoic acid on human sebaceous glands. Arch Dermatol Res (1980) 1.22
Binding to human jejunum of serum IgA antibody from children with coeliac disease. Lancet (1990) 1.22
Skin ageing. J Eur Acad Dermatol Venereol (2011) 1.21
Heat-shock protein 72 cell-surface expression on human lung carcinoma cells in associated with an increased sensitivity to lysis mediated by adherent natural killer cells. Cancer Immunol Immunother (1996) 1.19
Benign symmetric lipomatosis Launois-Bensaude. Report of ten cases and review of the literature. J Am Acad Dermatol (1987) 1.17
[Management of pyoderma gangrenosum. An update on clinical features, diagnosis and therapy]. Hautarzt (2010) 1.15
Simultaneous occurrence of folliculitis decalvans capillitii in identical twins. Br J Dermatol (2000) 1.13
Localization of collagen alpha 1(I) gene expression during wound healing by in situ hybridization. J Invest Dermatol (1989) 1.12
Cytokines, chemokines and growth factors in wound healing. J Eur Acad Dermatol Venereol (2011) 1.11
Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis. Arthritis Rheum (2001) 1.11
Plasma applications in medicine with a special focus on dermatology. J Eur Acad Dermatol Venereol (2011) 1.11
Occurrence of IgE-bearing epidermal Langerhans cells in atopic eczema: a study of the time course of the lesions and with regard to the IgE serum level. J Invest Dermatol (1989) 1.09
Papular elastorrhexis: a variant of dermatofibrosis lenticularis disseminata (Buschke-Ollendorff syndrome)? Dermatology (1994) 1.08
Classification of melanocytic lesions with color and texture analysis using digital image processing. Anal Quant Cytol Histol (1993) 1.08
Idiopathic trigeminal sensory neuropathy with gadolinium enhancement in the cisternal segment. Neurology (2000) 1.07
Indocyanine green (ICG) and laser irradiation induce photooxidation. Arch Dermatol Res (2000) 1.07
Fast and effective skin ablation with an Er:YAG laser: determination of ablation rates and thermal damage zones. Lasers Surg Med (1997) 1.06
Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas. Clin Cancer Res (1998) 1.06
Somatic FGFR3 and PIK3CA mutations are present in familial seborrhoeic keratoses. Br J Dermatol (2008) 1.06
Sequence changes in both flanking sequences of a pre-tRNA influence the cleavage specificity of RNase P. J Mol Biol (1991) 1.05
Lichen striatus and blaschkitis: reappraisal of the concept of blaschkolinear dermatoses. Br J Dermatol (2010) 1.05
Identification of differentially expressed genes in models of melanoma progression by cDNA array analysis: SPARC, MIF and a novel cathepsin protease characterize aggressive phenotypes. Exp Dermatol (2003) 1.03
Does switching from cigarettes to pipes or cigars reduce tobacco smoke exposure? Am J Public Health (1987) 1.02
Treatment of active psoriatic arthritis with the PPARgamma ligand pioglitazone: an open-label pilot study. Rheumatology (Oxford) (2004) 1.02
Q-switch laser and tattoo pigments: first results of the chemical and photophysical analysis of 41 compounds. Lasers Surg Med (2000) 1.02
Treatment of diffuse plane xanthoma of the face with the Erbium:YAG laser. Arch Dermatol (2001) 1.02
Dacarbazine and interferon alpha with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG). Br J Cancer (2001) 1.02
Photostability and thermal stability of indocyanine green. J Photochem Photobiol B (1998) 1.01
Tumor cell growth fractions in human malignant melanomas and the correlation to histopathologic tumor grading. Am J Pathol (1989) 1.01
Penetration potency of topical applied delta-aminolevulinic acid for photodynamic therapy of basal cell carcinoma. Photochem Photobiol (1994) 1.01
Teledermoscopy--results of a multicentre study on 43 pigmented skin lesions. J Telemed Telecare (2000) 1.01
Ultrastructural binding sites of endomysium antibodies from sera of patients with dermatitis herpetiformis and coeliac disease. Gut (1992) 1.00
Keratinocyte-derived cytokines after photodynamic therapy and their paracrine induction of matrix metalloproteinases in fibroblasts. Br J Dermatol (2004) 0.99
Long-term results in the treatment of childhood hemangioma with the flashlamp-pumped pulsed dye laser: an evaluation of 617 cases. Lasers Surg Med (2001) 0.98
FGFR3, PIK3CA and RAS mutations in benign lichenoid keratosis. Br J Dermatol (2012) 0.97
A probabilistic procedure for grouping words into phrases. Lang Speech (1966) 0.97
Indocyanine green and laser light for the treatment of AIDS-associated cutaneous Kaposi's sarcoma. Br J Cancer (1998) 0.97
[Erythema scarlatiniforme desquamativum recidivans localisatum]. Hautarzt (1985) 0.97
Wells' syndrome associated with idiopathic hypereosinophilic syndrome. Br J Dermatol (1997) 0.97
Ehlers-Danlos type VIII. Review of the literature. Clin Oral Investig (2000) 0.96
Noncytotoxic alkyl-lysophospholipid treatment increases sensitivity of leukemic K562 cells to lysis by natural killer (NK) cells. Int J Cancer (1996) 0.96
In situ expression patterns of melanoma-inhibiting activity (MIA) in melanomas and breast cancers. J Pathol (1999) 0.96
Dose-intensified bi-weekly temozolomide in patients with asymptomatic brain metastases from malignant melanoma: a phase II DeCOG/ADO study. Ann Oncol (2006) 0.96
Successful treatment of psoriatic onycho-pachydermo periostitis (POPP) with adalimumab. Arthritis Rheum (2005) 0.95
Long-term dermoscopic follow-up of melanocytic naevi: clinical outcome and patient compliance. Br J Dermatol (2003) 0.94
[Porokeratosis Mibelli gigantea: case report and literature review]. Hautarzt (1999) 0.94